Ramón García-Sanz

69PUBLICATIONS
466CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical biotechnology diagnostics (incl. biosensors)AutoimmunityHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (69)

|Aug 27, 2026
Radiation-Free Therapy for the Initial Treatment of Good Prognosis Early Non-Bulky Hodgkin Lymphoma, Defined by a Low Metabolic Tumor Volume and a Negative Interim PET After 2 Chemotherapy Cycles: The RAFTING Trial Protocol.

|May 14, 2026
Development and validation of a novel prognostic index for mantle cell lymphoma integrating TP53 mutations (MIPI53).

|Mar 19, 2026
Quantitative MYD88 L265P and flow cytometry levels for outcome determination in IgM gammopathies: the SAL-TO study.

Irene Dogliotti, Cristina Jiménez, Veronica Peri

|Mar 11, 2026
Genetic Evidence against Clonotypic B Lymphocytes as a Reservoir for Plasma-cell Cancers.

Carmen González, Juan-Jose Garces, Hector Gracia

|Nov 03, 2025
Noninvasive genotyping and early disease dynamics demonstrate the efficacy of ibrutinib in combination with immunochemotherapy in patients with mantle cell lymphoma treated in the TRIANGLE trial.

Mouhamad Khouja, Elisa Genuardi, Simone Ferrero

|Aug 01, 2025
NK Alloreactivity Evaluation According to KIR-HLA Interaction Models Influences the Outcome of Haploidentical Haematopoietic Stem-Cell Transplantation Based on Post-Transplant Cyclophosphamide.

Jairo Eduardo Niño-Ramírez, Francisco Javier Gil-Etayo, Marta Fonseca-Santos

Pageof 12

Frequent Collaborators

12 joint publications

Miguel Alcoceba

11 joint publications

María-Victoria Mateos

11 joint publications

Cristina Jiménez

10 joint publications

Alejandro Medina-Herrera